Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Lomvastomig by F. Hoffmann-La Roche for Metastatic Melanoma: Likelihood of Approval
Lomvastomig is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Metastatic Melanoma. According to GlobalData,...
Lomvastomig by F. Hoffmann-La Roche for Small-Cell Lung Cancer: Likelihood of Approval
Lomvastomig is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Small-Cell Lung Cancer. According to...
Lomvastomig by F. Hoffmann-La Roche for Non-Small Cell Lung Cancer: Likelihood of Approval
Lomvastomig is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Non-Small Cell Lung Cancer. According...